ACE2 and COVID-19: Glycyrrhizic acid (GA), the main active compound of the root of Glycyrrhiza uralensis (licorice), was suggested as a possible candidate for COVID-19 treatment, based on its ability to reduce SARS-CoV-2 invasion by blocking the ACE2-S protein binding, as reported in human embryonic kidney 239 T cells (161).